Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Oncology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters

Melanoma Clinical Trials

A listing of Melanoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (65) clinical trials

Patients are needed to participate in a clinical research study for the treatment of Carcinoma, skin cancer, Neuroendocrine Tumor, Adenocarcinoma, melanoma

BACKGROUND Patients receiving care at the NIH Clinical Center are required to be enrolled in a clinical protocol Following participation in a treatment protocol, it may be in the best interest of the patient to continue to be followed at the Clinical Center The NCI Surgery Branch conducts clinical trials ...

Phase N/A

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study.

This is a multi-center, open label, phase IV study to provide continued supply of pasireotide to patients being treated in a current Novartis-sponsored, Oncology CD&MA study and who are benefiting from treatment with pasireotide. Eligible patients are to be consented and can then continue treatment with pasireotide in this protocol. ...


Potential Research Study Participant Registry

Methods Subjects will self identify themselves via the UCDMC Dermatology website to complete a survey regarding their interest in learning about future dermatology clinical research projects. Subjects provide contact information and check of a list of potential topics of interest. Procedures Potential participants will find a link on the UCDMC ...

Phase N/A

A clinical trial seeking patients for a research study for the treatment of skin cancer, melanoma

The purpose of this study is to see if BMS-986205 combined with nivolumab, compared to nivolumab by itself, is more effective in treating Melanoma that has spread or is unable to be removed by surgery, and has not previously been treated


A Phase 1/2 clinical study for patients with Stage III Cutaneous Melanoma AJCC v7, BRAF V600E Mutation Present, Metastatic Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7, BRAF V600K Mutation Present, Solid Neoplasm

PRIMARY OBJECTIVES: I. To determine the maximum tolerated dose (MTD), toxicity, and safety profile of navitoclax when given in combination with dabrafenib and trametinib in patients with BRAF-mutant solid tumors. (Phase I) II. To estimate the complete response (CR) rate in patients with BRAF-mutant melanoma treated with dabrafenib, trametinib, and ...


Patients are needed to participate in a clinical research study to evaluate skin cancer, melanoma

This is a Phase 1 dose escalation study designed to find the highest dose of TIL 1383I TCR transduced T cells that can safely be given. Three cohorts of 3 patients will be treated with increasing doses of TIL 1383I TCR transduced T cells. Patients will be monitored clinically and ...


A clinical trial seeking patients for a research study for the treatment of Advanced Cutaneous Melanoma

Time Perspective: this study does have a retrospective component involving a subset of patients.

Phase N/A

A clinical trial seeking patients for a research study of Romidepsin

PRIMARY OBJECTIVES: I. To establish the safety and tolerability of romidepsin given on days 1, 8, and 15 of a 28 day cycle to patients with varying degrees of liver dysfunction (mild, moderate and severe). II. To establish the maximum tolerated dose (MTD) and appropriate dosing recommendations for romidepsin in ...


Study of Lymphodepletion Plus Adoptive Cell Transfer With T-Cells Transduced With CXCR2 and NGFR Followed by High Dose Interleukin-2 in Patients With Metastatic Melanoma

Pretreatment Procedures: If you are found eligible to take part in this study, the following tests and procedures will be performed before you begin receiving any study drugs or treatments: Within 6 months before receiving cyclophosphamide and fludarabine: You will have a lung function test. You will have a cardiac ...


A clinical trial to evaluate treatments for patients with skin cancer, Pigmented nevus, melanoma, Dysplastic Nevus

To date 557 subjects, including cases of melanoma and unaffected relatives, have been recruited in the family study of melanoma at the Bufalini Hospital, Cesena, Italy, University ofl'Aquila, L'Aquila, Italy, and the Istituto Valenciano de Oncologia, Valencia, Spain. Clinical characteristics of melanoma in the families studied were similar to those ...

Phase N/A